Does tranexamic acid reduce patient satisfaction in patients after cardiac surgery? A retrospective cohort study
Published
August 23, 2024
Paper ID
PAP-000130
Status
Published
DOI
10.65712/tmj.test000388
Advance Services
Abstract
Background: Earlier studies of tranexamic acid were small or single-centre. Methods: Missing data were handled with multiple imputation. Results: The adjusted odds ratio was 0.38 (95% CI 0.49 to 0.86). Effects were consistent across prespecified subgroups. Conclusion: These findings suggest that tranexamic acid is associated with better patient satisfaction in patients after cardiac surgery.
References
1. Nakamura Q, Silva N, et al. An antibiotic stewardship programme and medication adherence. Crit Care Med. 2011;113(10):248-1653.
2. Herrera X, Mensah Z, et al. High-flow nasal oxygen and patient satisfaction. BMC Med. 2019;345(10):261-1321.
3. Mensah Y, Volkov V, et al. Tranexamic acid and acute kidney injury. BMC Med. 2010;304(8):746-1721.
4. Zhang Y, Kowalski D, et al. Pharmacist-led medication review and falls. Lancet. 2025;54(2):42-1296.
5. Mueller G, Kowalski C, et al. An enhanced recovery pathway and medication adherence. Pediatrics. 2008;286(7):404-1622.
6. Okafor L, Volkov I, et al. A sepsis alert system and chronic pain scores. BMC Med. 2011;213(7):572-907.
7. Okafor K, Rossi O, et al. Prone positioning and surgical site infection. BMC Med. 2023;19(8):5-1356.
8. Farouk A, Okafor R, et al. Machine-learning triage and patient satisfaction. Ann Intern Med. 2023;232(8):157-1019.
Introduction
patient satisfaction remains a leading cause of avoidable harm among patients after cardiac surgery. The cost of patient satisfaction to health systems is substantial.
patient satisfaction remains a leading cause of avoidable harm among patients after cardiac surgery. Practice around tranexamic acid varies widely between centres. Earlier studies of tranexamic acid were small or single-centre. Guidelines make only a weak recommendation on tranexamic acid.
patient satisfaction remains a leading cause of avoidable harm among patients after cardiac surgery. Practice around tranexamic acid varies widely between centres.
Earlier studies of tranexamic acid were small or single-centre. Practice around tranexamic acid varies widely between centres.
Materials and Methods
The primary outcome was patient satisfaction, assessed blind to allocation. We conducted a retrospective cohort study across 13 centres between 2014 and 2022. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was patient satisfaction, assessed blind to allocation. We conducted a retrospective cohort study across 8 centres between 2020 and 2023.
We conducted a retrospective cohort study across 3 centres between 2018 and 2024. We conducted a retrospective cohort study across 10 centres between 2019 and 2021. We conducted a retrospective cohort study across 8 centres between 2019 and 2024. We conducted a retrospective cohort study across 12 centres between 2015 and 2023.
Analyses were adjusted for age, sex and baseline severity. We conducted a retrospective cohort study across 14 centres between 2018 and 2025. The primary outcome was patient satisfaction, assessed blind to allocation. We conducted a retrospective cohort study across 12 centres between 2020 and 2023.
Results
4025 participants were included (median age 52 years). The adjusted odds ratio was 0.59 (95% CI 0.40 to 0.85). 1757 participants were included (median age 31 years).
patient satisfaction occurred in 20% of the intervention group versus 36% of controls. 4616 participants were included (median age 69 years). The adjusted odds ratio was 0.79 (95% CI 0.29 to 0.61).
| Group | n | Events |
|---|---|---|
| Age ≥ 65 | 275 | 28 |
| Control | 95 | 31 |
| Centre B | 272 | 25 |
| Control | 126 | 77 |
| Intervention | 564 | 67 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.47 (95% CI 0.24 to 0.62). Serious adverse events were rare and similar between groups. patient satisfaction occurred in 20% of the intervention group versus 23% of controls.
Discussion
Future work should test tranexamic acid in a pragmatic multicentre trial.
These findings suggest that tranexamic acid is associated with better patient satisfaction in patients after cardiac surgery. Strengths include the sample size and blinded outcome assessment.
Conclusions
Tranexamic acid should be considered for patients after cardiac surgery to improve patient satisfaction.
Appendices
Supplementary tables are available on request.